Vikram Chaudhari
Overview
Explore the profile of Vikram Chaudhari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noronha V, Patil V, Menon N, Kolkur M, Peelay Z, Shah M, et al.
BMJ Oncol
. 2025 Jan;
3(1):e000445.
PMID: 39886158
Objective: Older patients with cancer have traditionally been under-represented in global clinical trials. There are no data from India regarding this issue. Methods And Analysis: This was a retrospective analysis...
2.
Nandy K, Patel D, Kaderi A, Deshpande G, Ostwal V, Ramaswamy A, et al.
J Gastrointest Surg
. 2024 Aug;
28(11):1805-1811.
PMID: 39181233
Background: Extra-ampullary duodenal adenocarcinoma is a rare neoplasm. The data on long-term outcomes after curative resection are limited, and the role of systemic chemotherapy is not defined in these tumors....
3.
Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, et al.
HPB (Oxford)
. 2024 Jul;
26(10):1261-1269.
PMID: 39019675
Background: The role of adjuvant therapy in resected periampullary adenocarcinomas is equivocal due to contrasting data and limited prospective trials. Methods: The Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP),...
4.
Batra S, Bhandare M, Chaudhari V, Esha P, Nikhil M, Ostwal V, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):7142-7156.
PMID: 39014164
Background: Outside of clinical trials, real-world data of advanced gastric cancers (AGCs) managed with perioperative or adjuvant chemotherapy with a backbone of D2 lymphadenectomy is limited. Patients And Methods: Curative...
5.
Puranik A, Rangarajan V, Shetty N, Gala K, Kulkarni S, Mohite A, et al.
Indian J Nucl Med
. 2024 Jul;
39(2):71-76.
PMID: 38989301
Purpose: We proposed to administer Lu-177-DOTATATE in intra-arterial (IA) mode for higher first-pass localization to somatostatin receptors, higher residence time in liver metastases, and more radiation to tumor. This study...
6.
Patkar S, Shetty O, Vyas K, Vengurlekar V, Kamble V, Shetty N, et al.
J Clin Exp Hepatol
. 2024 Jul;
14(6):101445.
PMID: 38975607
Introduction: Circulating tumor cells are a promising biomarker in many malignancies. CTC dissemination during the operative procedure can lead to disease recurrence. The effect of preoperative transarterial embolization on the...
7.
Bhandare M, Gupta V, Chaudhari V, Nandy K, Ostwal V, Ramaswamy A, et al.
HPB (Oxford)
. 2024 Jun;
26(10):1237-1247.
PMID: 38944571
Background: CA 19-9 is an extremely useful biomarker for pancreatic ductal adenocarcinomas (PDACs). However, the optimal cut-off and prognostic significance at higher cut-offs are yet to be determined. Methods: Retrospective...
8.
Bhandare M, Varty G, Reddy Obili R, Chopde A, Pawar A, Krishnakumar K, et al.
Ann Surg
. 2024 Jun;
PMID: 38939924
Objective: To determine the clinical utility of serum CA 19-9 surveillance for detecting recurrences in resected ampullary carcinomas (ACs). Introduction: Although an established prognostic marker for pancreatic ductal adenocarcinoma, the...
9.
Bhandare M, Gundavda K, Yelamanchi R, Chopde A, Batra S, Kolhe M, et al.
Eur J Surg Oncol
. 2024 Apr;
50(6):108343.
PMID: 38640606
Background: Advances in perioperative chemotherapy have improved outcomes in patients with gastric cancers (GC). This strategy leads to tumour downstaging and may result in a pathologic complete response (pCR). The...
10.
Gupta V, Chopde A, Chaudhari V, Bal M, Shrikhande S, Bhandare M
J Gastrointest Cancer
. 2024 Feb;
55(2):572-583.
PMID: 38324136
Purpose: GISTs arising from organs outside GI tract are defined as extragastrointestinal GISTs (EGIST). The majority of EGISTs arise from small intestinal mesentry, mesocolon, omentum, retroperitoneum, abdominal wall, liver and...